Glioma
Showing 51 - 75 of 370
Glioma, Fear of Cancer Trial in Richmond (FearLess Intervention)
Recruiting
- Glioma
- Fear of Cancer
- FearLess Intervention
-
Richmond, VirginiaVirginia Commonwealth University
Dec 16, 2022
CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (HER2-specific chimeric antigen receptor (CAR) T cell)
Recruiting
- Central Nervous System Tumor, Pediatric
- +8 more
- HER2-specific chimeric antigen receptor (CAR) T cell
-
Seattle, WashingtonSeattle Children's Hospital
Dec 14, 2022
Glioma Trial in Boston (Supplemental High Fat Low Carbohydrate (sHFLC) + KetoPhyt)
Not yet recruiting
- Glioma
- Supplemental High Fat Low Carbohydrate (sHFLC) + KetoPhyt
-
Boston, MassachusettsTufts Medical Center
Dec 8, 2022
Glioma Trial in Rochester (Early START visit using checklist over telephone or zoom)
Recruiting
- Glioma
- Early START visit using checklist over telephone or zoom
-
Rochester, New YorkUniversity of Rochester
Dec 6, 2022
Glioblastoma, Glioma, Breast Cancer Trial in France (QMRP questionnaire)
Recruiting
- Glioblastoma
- +3 more
- QMRP questionnaire
-
Montpellier, Herault, France
- +5 more
Nov 29, 2022
Glioma, Radiation Therapy Patient Trial in Houston (FitBit, Pedometer, Quality-of-Life Assessment)
Recruiting
- Glioma
- Radiation Therapy Patient
- FitBit
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Nov 28, 2022
H3 K27M, Glioma Trial in Santa Monica (ONC201, ONC201 + Placebo, Placebo)
Recruiting
- H3 K27M
- Glioma
- ONC201
- +2 more
-
Santa Monica, CaliforniaProvidence Saint John's Cancer Institute
Nov 28, 2022
Glioma Trial in Winston-Salem (device, procedure, other)
Recruiting
- Glioma
- Cereset Research Wearable
- +3 more
-
Winston-Salem, North CarolinaWake Forest Baptist Comprehensive Cancer Center
Nov 17, 2022
Glioma Trial in Madison (Bevacizumab, PRDR)
Recruiting
- Glioma
- Bevacizumab
- PRDR
-
Madison, WisconsinUniversity of Wisconsin Hospital and Clinics
Nov 14, 2022
Glioma, Recurrent Glioma Trial in Shanghai (Hypofractionated Stereotactic Radiotherapy, Bevacizumab)
Active, not recruiting
- Glioma
- Recurrent Glioma
- Hypofractionated Stereotactic Radiotherapy
- Bevacizumab
-
Shanghai, Shanghai, ChinaCyberKnife Center, Department of Neurosurgery, Huashan Hospital
Nov 3, 2022
Glioblastoma, Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma Trial in New York (Intra-arterial Cetuximab, Intra-arterial
Recruiting
- Glioblastoma
- +8 more
- Intra-arterial Cetuximab
- +2 more
-
New York, New YorkLenox Hill Brain Tumor Center
Oct 17, 2022
Glioma Trial in Melbourne (Biopsy, Part A: AB-218, Surgery (maximal resection))
Recruiting
- Glioma
- Biopsy
- +3 more
-
Melbourne, Victoria, AustraliaRoyal Melbourne Hospital
Oct 11, 2022
Neurocognition & Neuroimaging in Primary BT Patients
Recruiting
- Primary Brain Tumor
- +3 more
-
San Diego, CaliforniaMoores Cancer Center
Oct 7, 2022
Glioblastoma, Brain Tumor, Glioma Trial in United States (Procedure: LITT, Hypo-Fractionated Radiation Therapy)
Recruiting
- Glioblastoma
- +3 more
- Procedure: LITT
- Hypo-Fractionated Radiation Therapy
-
Baltimore, Maryland
- +3 more
Oct 10, 2022
Glioma Trial in Beijing (68Ga-P16-093)
Recruiting
- Glioma
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Oct 4, 2022
Glioma, High Grade Glioma, Pontine Tumors Trial in Ann Arbor (Dasatinib, Everolimus)
Terminated
- Glioma
- +2 more
-
Ann Arbor, MichiganUniversity of Michigan Cancer Center
Sep 26, 2022
Glioma, Low-grade Glioma, Low Grade Glioma of Brain Trial in Philadelphia (18F-Fluciclovine)
Not yet recruiting
- Glioma
- +4 more
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Oct 3, 2022
Oligodendroglioma, Astrocytoma, Grade II, Glioma, Astrocytic Trial in San Francisco (GBM6-AD and poly-ICLC before and after
Active, not recruiting
- Oligodendroglioma
- +5 more
- GBM6-AD and poly-ICLC before and after surgery
- GBM6-AD and poly-ICLC after surgery only
-
San Francisco, CaliforniaUniversity of California
Sep 20, 2022